--- title: "GLP-1 Side Effects" description: "Common and serious GLP-1 side effects: nausea, pancreatitis, thyroid risk, and what Indian patients should watch for during titration." canonical: "https://www.kesho.health/keywords/glp-1-side-effects" markdown_url: "https://www.kesho.health/md/keywords/glp-1-side-effects" language: "en-IN" primary_keyword: "GLP-1 side effects" --- # GLP-1 side effects — what to expect and when to worry > **Short answer:** The most common GLP-1 side effects are gastrointestinal: nausea, vomiting, diarrhoea, and bloating — especially during dose titration in the first 4–8 weeks. Serious risks include pancreatitis and contraindication in MTC/MEN2. Most patients adapt with gradual dose increases and dietary adjustments. **Canonical HTML:** https://www.kesho.health/keywords/glp-1-side-effects **Markdown:** https://www.kesho.health/md/keywords/glp-1-side-effects ## Side effects on therapy **GLP-1 readiness check** — Educational self-assessment on eligibility signals, safety flags, and what to discuss with your doctor — not a prescription. [GLP-1 readiness check](https://www.kesho.health/glp-1-assessment) **Find a specialist** — Legitimate endocrinologist and diabetologist pathways in your city — Kesho does not take bookings or list individual doctors. [Find a specialist](https://www.kesho.health/find-specialist) ## Common side effects during titration Nausea affects 20–40% of patients during early weeks. Eating smaller portions, avoiding greasy foods, and following your doctor's titration schedule helps. Symptoms usually improve as the body adapts. ## Serious warning signs Seek emergency care for severe persistent abdominal pain (pancreatitis), signs of dehydration from vomiting, or allergic reactions. Report neck lumps or hoarseness promptly given thyroid precautions. ## Side effects specific to Indian context Dehydration risk increases in summer heat — stay hydrated especially during titration. Vegetarian patients should monitor protein intake when appetite drops to prevent muscle loss. ## Thyroid and pancreatitis precautions GLP-1 RAs carry precautions for medullary thyroid carcinoma and MEN2 syndrome—contraindicated in those histories. Pancreatitis is rare but serious; severe persistent upper abdominal pain radiating to the back requires emergency evaluation. Indian patients with prior gallstone disease should discuss risk with their physician before starting. ## Managing nausea during Indian meal patterns Smaller dal–roti or idli portions, avoiding heavy fried foods during titration, and eating slowly reduce nausea without sacrificing cultural meal structure. Some patients tolerate injections at bedtime. Ginger tea and clear fluids help mild symptoms—report vomiting lasting more than twenty-four hours. ## When to call your doctor vs emergency care Call your prescribing physician for persistent nausea beyond two weeks, constipation, or injection-site reactions. Go to emergency for severe abdominal pain, allergic swelling, breathing difficulty, or signs of dehydration (dizziness, dark urine, inability to keep fluids down). Keep your endocrinologist's after-hours contact saved during the first two months. ## Long-term safety monitoring in India RSSDI follow-up typically includes periodic HbA1c, kidney function, lipids, and weight tracking. Report neck lumps, hoarseness, or vision changes. GLP-1 RAs are chronic therapies—side-effect profiles evolve over months, not days. Do not stop abruptly without medical guidance. ## Injection site rotation and technique Rotate abdomen, thigh, and upper arm sites to reduce lipodystrophy. Use new needles each injection. Indian patients new to self-injection should request nurse demonstration at first dose—many endocrine clinics offer brief training sessions. Proper technique reduces bruising and improves absorption consistency. ## Full safety guide on Kesho Our cornerstone side-effects guide covers GI symptoms, pancreatitis, thyroid precautions, MTC/MEN2 contraindications, and Indian summer dehydration risks in 3,800+ words with PubMed references. Use this landing page for quick orientation; the full guide supports shared decision-making with your physician. ## Mental health and appetite changes Rapid appetite reduction can affect mood or social eating patterns—discuss significant anxiety or low mood with your doctor. GLP-1 RAs are not substitutes for eating-disorder treatment. Family support helps when festival or wedding seasons conflict with smaller portion goals during titration. ## Reporting adverse events in India Report suspected adverse reactions through your physician or CDSCO pharmacovigilance channels. Document batch numbers and storage conditions if pens may have degraded in heat. Accurate reporting improves national safety data for Indian patients starting incretin therapy. ## Constipation and GI slowing GLP-1 RAs slow gastric emptying—constipation may accompany nausea. Increase fibre gradually, hydrate well in Indian summers, and walk after meals when tolerated. Persistent severe constipation warrants medical review; do not rely on unsupervised laxative stacks from pharmacy counters without physician advice. ## Hypoglycaemia when combined with other drugs GLP-1 alone rarely causes hypoglycaemia, but risk rises with sulfonylureas or insulin. Indian patients on combination regimens should carry glucose sources and educate family members about symptoms. Monitor fasting glucose during titration when companion diabetes medicines are present. ## Gallbladder and pancreatic history Patients with prior gallstones or pancreatitis need individualised risk assessment before GLP-1 initiation. Report post-meal right upper abdominal pain promptly. History alone is not always contraindication—specialist judgment applies per RSSDI context. ## Alcohol during titration Alcohol worsens nausea and dehydration during early GLP-1 titration—many physicians advise minimising intake in first eight weeks. Indian wedding and festival seasons may conflict with titration timing; plan start dates with your doctor when possible. ## Exercise while managing side effects Light walking after meals may aid glucose control without intensifying nausea. Avoid high-intensity gym sessions during first titration month if GI symptoms are active. Resume resistance training gradually as appetite stabilises—protein intake supports muscle preservation on GLP-1 therapy. Discuss exercise plans with your physician if you have heart or joint conditions. ## Side-effect diary for follow-up Log nausea severity, bowel changes, injection sites, and weight weekly during titration. Share logs at follow-up—Indian corridor consultations are short and structured notes improve care quality. Kesho safety guide lists emergency symptoms requiring same-day evaluation. ## Quick questions ### Is GLP-1 Side Effects information on Kesho medical advice? No. Kesho provides drug-class education only. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised treatment decisions. ### Where is the full guide? See our complete medically reviewed guide linked on this page for in-depth coverage with references and India-specific context. ### What is the short answer on glp-1 side effects? The most common GLP-1 side effects are gastrointestinal: nausea, vomiting, diarrhoea, and bloating — especially during dose titration in the first 4–8 weeks. Serious risks include pancreatitis and contraindication in MTC/MEN2. Most patients adapt with gradual dose increases and dietary adjustments. ## Complete guide [glp-1-side-effects-safety](https://www.kesho.health/blog/glp-1-side-effects-safety) · [MD](https://www.kesho.health/md/blog/glp-1-side-effects-safety) ## Related guides - [Is Semaglutide Safe in India? What Patients Should Know](https://www.kesho.health/blog/is-semaglutide-safe-india) - [GLP-1 and Thyroid Health: What Indian Patients Should Know](https://www.kesho.health/blog/glp-1-and-thyroid-what-to-know) - [Nutrition on GLP-1 Therapy: An India-Focused Guide](https://www.kesho.health/blog/glp-1-nutrition-guide-india) --- *Drug-class education only — not medical advice. [Kesho](https://www.kesho.health)*